BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 181183)

  • 1. Primary hyperlipoproteinemia in xanthomatosis.
    Hessel LW; Vermeer BJ; Polano MK; De Jonge H; De Pagter HA; Van Gent CM
    Clin Chim Acta; 1976 Jun; 69(3):405-16. PubMed ID: 181183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthomatosis and other clinical findings in patients with elevated levels of very low density lipoproteins.
    Vermeer BJ; van Gent CM; Goslings B; Polano MK
    Br J Dermatol; 1979 Jun; 100(6):657-66. PubMed ID: 223620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normocholesterolemic dysbetalipoproteinemia with xanthomatosis.
    Abrams JJ; Grundy SM; Kane JP; Chang CM
    Metabolism; 1979 Feb; 28(2):113-24. PubMed ID: 216881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
    Falko JM; Witztum JL; Schonfeld G; Weidman SW; Kolar JB
    Am J Med; 1979 Feb; 66(2):303-10. PubMed ID: 218451
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies in asymptomatic primary hyperlipidaemia II. Clinical findings.
    Olsson AG
    Acta Med Scand; 1975 Jun; 197(6):477-85. PubMed ID: 168737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Xanthomatosis eruptiva papulosa (hyperlipoproteinemia type V)].
    Vigh C; Czinder K; Mátyus L
    Z Hautkr; 1974 Oct; 49(19):819-28. PubMed ID: 4464725
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of xanthomatosis and hyperlipoproteinemia type V propably induced by overdosage of insulin.
    Vermeer BJ; Poland MK
    Dermatologica; 1975; 151(1):43-50. PubMed ID: 173587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 3 hyperlipoproteinaemia.
    Eisenberg S
    Clin Endocrinol Metab; 1973 Mar; 2(1):111-25. PubMed ID: 4359114
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum lipoprotein composition in different types of hyperlipoproteinemia.
    Carlson LA
    Adv Exp Med Biol; 1975; 63():185-99. PubMed ID: 173148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Classification of hyperlipoproteinemia. II. Distribution principle of hyperlipoproteinemias according to Fredrickson et al. correlated with clinical dermatological possibilities].
    Zabel R
    Dermatol Monatsschr; 1973 Dec; 159(12):1137-43. PubMed ID: 4366868
    [No Abstract]   [Full Text] [Related]  

  • 11. Type II hyperlipoproteinaemia.
    Myant NB; Slack J
    Clin Endocrinol Metab; 1973 Mar; 2(1):81-109. PubMed ID: 4361963
    [No Abstract]   [Full Text] [Related]  

  • 12. [Classification of hyperlipoproteinemias].
    Zabel R
    Dermatol Monatsschr; 1974 Feb; 160(2):134-50. PubMed ID: 4369507
    [No Abstract]   [Full Text] [Related]  

  • 13. Xanthomata in primary hyperlipoproteinemia. A classification based on the lipoprotein pattern of the blood.
    Polano MK; Baes H; Hulsmans HA; Querido A; Pries C; van Gent CM
    Arch Dermatol; 1969 Oct; 100(4):387-400. PubMed ID: 5358101
    [No Abstract]   [Full Text] [Related]  

  • 14. [Essential hypercholesteremic xanthomatosis (Frederickson's hyperlipoproteinemia type IIb)].
    Schink W
    Handchirurgie; 1976; 8(1):37. PubMed ID: 184012
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia.
    Vessby B; Hedstrand H; Olsson U
    Ups J Med Sci; 1976; 81(2):71-8. PubMed ID: 183321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biochemical, clinical, and genetic features of type III hyperlipoproteinemia.
    Morganroth J; Levy RI; Fredrickson DS
    Ann Intern Med; 1975 Feb; 82(2):158-74. PubMed ID: 163608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK
    Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should hyperlipidemia be treated? Available agents and clinical results.
    Gotto AM
    Cardiovasc Res Cent Bull; 1978; 17(1):3-27. PubMed ID: 223761
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differentiation of VLDL subfraction in the diagnosis of type III hyperlipoproteinaemias (author's transl)].
    Vogelberg KH
    J Clin Chem Clin Biochem; 1977 Jul; 15(7):389-92. PubMed ID: 197199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.